Related Experiment Videos
Cigarette smoking and clinically significant drug interactions
1Environmental and Occupational Health Sciences Institute, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, USA.
The Annals of Pharmacotherapy
|November 1, 1995
Summary
Cigarette smoking significantly impacts drug effectiveness through pharmacokinetic and pharmacodynamic interactions. Smokers may require higher drug doses, and interactions can increase adverse event risks, especially for cardiovascular and peptic ulcer conditions.
Area of Science:
- Pharmacology
- Clinical Medicine
- Drug Interactions
Background:
- Cigarette smoking is prevalent and known to influence physiological processes.
- Understanding drug interactions is crucial for effective patient management.
- Previous research has indicated potential links between smoking and altered drug responses.
Purpose of the Study:
- To comprehensively review clinically significant drug interactions associated with cigarette smoking.
- To identify specific drugs and drug classes affected by smoking.
- To elucidate the mechanisms underlying these interactions.
Main Methods:
- Systematic literature search of scientific publications using MEDLINE.
- Inclusion of data from clinical, epidemiologic, pharmacokinetic studies, and review articles.
- Evaluation and synthesis of findings from human studies published in English, focusing on clinically significant interactions.
Main Results:
- Cigarette smoking affects drug therapy through both pharmacokinetic and pharmacodynamic mechanisms.
- Pharmacokinetic interactions involve altered drug clearance, absorption, and enzyme induction (e.g., cytochrome P450).
- Pharmacodynamic interactions were noted for antihypertensives, antianginals, antilipidemics, oral contraceptives, and histamine2-receptor antagonists.
Conclusions:
- Smoking can reduce drug efficacy and lead to unpredictable therapeutic outcomes.
- Smokers may require adjusted dosages due to increased drug clearance or decreased absorption.
- Interactions pose risks for cardiovascular and peptic ulcer disease patients, and women using oral contraceptives.